{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:55:08Z","timestamp":1767117308216,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ymgmr.2024.101053","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T14:49:00Z","timestamp":1705589340000},"page":"101053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Long term follow-up in GAMT deficiency \u2013 Correlation of therapy regimen, biochemical and in vivo brain proton MR spectroscopy data"],"prefix":"10.1016","volume":"38","author":[{"given":"Lara M.","family":"Marten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Kr\u00e4tzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gajja S.","family":"Salomons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Fernandez Ojeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dechent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"G\u00e4rtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Huppke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffi","family":"Dreha-Kulaczewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1994","series-title":"Creatine Deficiency in the Brain: A New, Treatable Inborn Error of Metabolism","author":"Stockler","key":"10.1016\/j.ymgmr.2024.101053_bb0005"},{"issue":"5","key":"10.1016\/j.ymgmr.2024.101053_bb0010","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/323765","article-title":"Arginine: Glycine amidinotransferase deficiency: The Third inborn error of creatine metabolism in humans","volume":"69","author":"Item","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.79","article-title":"Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?","volume":"49","author":"Cecil","year":"2001","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0020","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/01.wnl.0000234852.43688.bf","article-title":"GAMT deficiency: features, treatment, and outcome in an inborn error of creatine synthesis","volume":"67","author":"Mercimek-Mahmutoglu","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0025","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/s-0034-1386772","article-title":"Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders","volume":"34","author":"Stockler-Ipsiroglu","year":"2014","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.ymgmr.2024.101053_bb0030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2015.10.022","article-title":"Creatine biosynthesis and transport in health and disease","volume":"119","author":"Joncquel-Chevalier Curt","year":"2015","journal-title":"Biochimie"},{"issue":"8","key":"10.1016\/j.ymgmr.2024.101053_bb0035","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00726-016-2189-0","article-title":"Creatine synthesis and exchanges between brain cells: what can be learned from human creatine deficiencies and various experimental models?","volume":"48","author":"Hanna-El-Daher","year":"2016","journal-title":"Amino Acids"},{"issue":"5","key":"10.1016\/j.ymgmr.2024.101053_bb0040","first-page":"914","article-title":"Guanidinoacetate methyltransferase deficiency: the first inborn error of creatine metabolism in man","volume":"58","author":"St\u00f6ckler","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2024.101053_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.15774","article-title":"Guanidinoacetate (GAA) is a potent GABAA receptor GABA mimetic: implications for neurological disease pathology","author":"Meera","year":"2023","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.ymgmr.2024.101053_bb0050","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3476(97)70075-1","article-title":"Creatine deficiency syndrome caused by guanidinoacetate methyltransferase deficiency: diagnostic tools for a new inborn error of metabolism","volume":"131","author":"Schulze","year":"1997","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101053_bb0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/gim.2016.203","article-title":"Laboratory diagnosis of creatine deficiency syndromes: a technical standard and guideline of the American College of Medical Genetics and Genomics","volume":"19","author":"Sharer","year":"2017","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101053_bb0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2013.10.018","article-title":"Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring","volume":"111","author":"Stockler-Ipsiroglu","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101053_bb0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mrm.20337","article-title":"Use of phased array coils for a determination of absolute metabolite concentrations","volume":"53","author":"Natt","year":"2005","journal-title":"Magn. Reson. Med."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101053_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mrm.1910090110","article-title":"Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brainin vivo","volume":"9","author":"Frahm","year":"1989","journal-title":"Magn. Reson. Med."},{"issue":"6","key":"10.1016\/j.ymgmr.2024.101053_bb0075","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mrm.1910300604","article-title":"Estimation of metabolite concentrations from localizedin vivo proton NMR spectra","volume":"30","author":"Provencher","year":"1993","journal-title":"Magn. Reson. Med."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ymgme.2004.05.001","article-title":"Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport","volume":"82","author":"Almeida","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ymgme.2004.04.009","article-title":"Guanidinoacetate and creatine\/creatinine levels in controls and patients with urea cycle defects","volume":"82","author":"Arias","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101053_bb0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.gene.2014.01.019","article-title":"Diagnosis and therapeutic monitoring of inborn errors of creatine metabolism and transport using liquid chromatography\u2013tandem mass spectrometry in urine, plasma and CSF","volume":"538","author":"Haas","year":"2014","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejpn.2018.02.007","article-title":"Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: an international retrospective cohort study","volume":"22","author":"Khaikin","year":"2018","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101053_bb0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2013.10.018","article-title":"Guanidinoacetate methyltransferase (GAMT) deficiency: outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring","volume":"111","author":"Stockler-Ipsiroglu","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgmr.2024.101053_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pediatrneurol.2014.02.011","article-title":"Case study for the evaluation of current treatment recommendations of Guanidinoacetate methyltransferase deficiency: ineffectiveness of sodium benzoate","volume":"51","author":"Mercimek-Mahmutoglu","year":"2014","journal-title":"Pediatr. Neurol."},{"issue":"8","key":"10.1016\/j.ymgmr.2024.101053_bb0110","first-page":"Aug 2016","article-title":"Creatine synthesis and exchanges between brain cells: What can be learned from human creatine deficiencies and various experimental models?","volume":"48","author":"Hanna-El-Daher","year":"1877","journal-title":"Amino Acids"},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2013.08.020","article-title":"Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency","volume":"110","author":"Viau","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2022.01.101","article-title":"Method modification to reduce false positives for newborn screening of guanidinoacetate methyltransferase deficiency","volume":"135","author":"Wojcik","year":"2022","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ymgmr.2024.101053_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymgme.2016.05.002","article-title":"A three-tier algorithm for guanidinoacetate methyltransferase (GAMT) deficiency newborn screening","volume":"118","author":"Sinclair","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2024.101053_bb0130","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymgme.2021.07.012","article-title":"Prospective identification by neonatal screening of patients with guanidinoacetate methyltransferase deficiency","volume":"134","author":"Hart","year":"2021","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgmr.2024.101053_bb0135","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062100","article-title":"Evidence and recommendation for Guanidinoacetate methyltransferase deficiency newborn screening","volume":"152","author":"Ream","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgmr.2024.101053_bb0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.omtm.2022.03.015","article-title":"Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities","volume":"25","author":"Khoja","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426924000065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:54:07Z","timestamp":1762001647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426924000065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S2214426924000065"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101053","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term follow-up in GAMT deficiency \u2013 Correlation of therapy regimen, biochemical and in vivo brain proton MR spectroscopy data","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2024.101053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101053"}}